The country manager of Berlin-Chemie / A. Menarini Hungary, Dr. Peter Olah, explains the impact of a more targeted sales force in driving the company in the last three years, while highlighting his ambitions to push the affiliate into more specialty care. He also describes the most salient challenges currently facing pharmaceutical companies in Hungary and several characteristics that distinguish the market from others in the region.
Having just passed your three-year anniversary, Peter, how would you evaluate the company’s performance under your leadership? Did you accomplish all the objectives you had initially set out to achieve?
I stepped into the role of country manager in January 2013, at which point the annual turnover stood at EUR 19.5 million.
Given the circumstances in this country, companies need to be flexible, agile, and adapt quickly in order to succeed.
